Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.
机构：[1]Department of Liver Diseases of Chinese PLA General Hospital, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.[2]Department of Infectious and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.[3]Department of Infectious Disease, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.[4]Fuzhou Infectious Diseases Hospital, Fuzhou, Fujian Province, China.[5]Department of Clinical &Translational Medicine, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.[6]Liver Disease Department, Fuyang 2nd People's Hospital, Fuyang, Anhui Province, China.[7]Department of Infectious Diseases, Southwest Hospital, the Third Military Medical University, Chongqing, China.[8]Therapeutic Center for Liver Disease, the 88th Hospital of PLA, Taian, Shandong Province, China.[9]Guangzhou 8th People's Hospital, Guangzhou, Guangdong Province, China.[10]Department of Hepatic Diseases, Shanghai Public Health Clinical Center, Shanghai, China.[11]National Integrative Medicine Clinical Base for Infectious Diseases and Department of Infectious Diseases, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.[12]Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.[13]Traditional Chinese Medicine Hospital of Chongqing, Chongqing, China.[14]Tianjin Second People's Hospital, Tianjin Institute of Hepatology, Tianjin, China.[15]Division of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia, V6T1Z4 Canada.[16]Liver Research Unit Medica Sur Clinic &Foundation &Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.[17]Division of Gastroenterology and Hepatology, University of California, Irvine, School of Medicine, Orange, CA, USA.[18]Department of Gastroenterology, General Hospital of Northern Theater Command (formerly General Hospital of Shenyang Military Area), Shenyang, Liaoning Province, China.
This work was supported in part by
the State Key Projects Specialized on Infectious Disease,
Chinese Ministry of Science and Technology (grant number
2013ZX10005002) and the Beijing Key Research Project of
Special Clinical Application (grant number Z151100004015221)
to Y. Y.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|2 区医学
小类|2 区免疫学2 区传染病学2 区微生物学
最新[2025]版：
大类|2 区医学
小类|2 区免疫学2 区传染病学2 区微生物学
第一作者：
第一作者机构：[1]Department of Liver Diseases of Chinese PLA General Hospital, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Liver Diseases of Chinese PLA General Hospital, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.[*1]Department of Liver Diseases & the Fifth Medical Center of the Chinese People’s Liberation Army General Hospital, Beijing 100039, China
推荐引用方式(GB/T 7714)：
Rong Guanghua,Chen Yongping,Yu Zujiang,et al.Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.[J].The Journal Of Infectious Diseases.2020,doi:10.1093/infdis/jiaa266.
APA：
Rong Guanghua,Chen Yongping,Yu Zujiang,Li Qin,Bi Jingfeng...&Yang Yongping.(2020).Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial..The Journal Of Infectious Diseases,,
MLA：
Rong Guanghua,et al."Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.".The Journal Of Infectious Diseases .(2020)
医学